Show simple item record

Electrophysiological effects of prazosin during acute myocardial ischemia

dc.contributor.authorWilber, David J.en_US
dc.contributor.authorLynch, Joseph J.en_US
dc.contributor.authorLucchesi, Benedict Roberten_US
dc.date.accessioned2006-04-07T19:27:51Z
dc.date.available2006-04-07T19:27:51Z
dc.date.issued1986-08en_US
dc.identifier.citationWilber, David J., Lynch, Joseph J., Lucchesi, Benedict R. (1986/08)."Electrophysiological effects of prazosin during acute myocardial ischemia." European Journal of Pharmacology 127(1-2): 157-161. <http://hdl.handle.net/2027.42/26081>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6T1J-475SKKW-7M/2/077a2ec4fe1905ec10cdd421e1ddd348en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/26081
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3019724&dopt=citationen_US
dc.description.abstractPrazosin, 100 [mu]g/kg, had no effect on baseline refractoriness or intraventricular conduction in anesthetized dogs. During 1 h of coronary artery occlusion followed by reperfusion, prazosin significantly blunted the shortening of the ventricular effective refractory periods within ischemic myocardial region relative to vehicle-treated animals. Prazosin treatment also prevented the delayed conduction of paced ventricular complexes entering and exiting the ischemic zone. These effects may be associated with the blockade of [alpha]1-adrenoceptor activation during the acute phase of myocardial ischemia.en_US
dc.format.extent442951 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleElectrophysiological effects of prazosin during acute myocardial ischemiaen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartments of Pharmacology and Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109-0010, U.S.Aen_US
dc.contributor.affiliationumDepartments of Pharmacology and Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109-0010, U.S.Aen_US
dc.contributor.affiliationumDepartments of Pharmacology and Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109-0010, U.S.Aen_US
dc.identifier.pmid3019724en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/26081/1/0000157.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0014-2999(86)90220-7en_US
dc.identifier.sourceEuropean Journal of Pharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.